. . january 2014 (16) . staff blog: medicine matters . . . .eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. . http://lm360.us/Carioscia-father-of-Winge-from-Bucharest?Eskelsenb=153 mayo clinic: "migraine: diagnosis & treatment," "monoclonal antibody drugs for cancer: how they work." . .chemotherapy involved two hours at the hospital every other week. he'd leave wearing a fanny pack that would continue to deliver treatment for 48 straight hours, one slow drip at a time. . . ..